Guangzhou Baiyunshan Pharmaceutical Holdings Company Financial Overview
Guangzhou Baiyunshan Pharmaceutical Holdings Company's market cap is currently HK$44.27B. The company's EPS TTM is HK$0.53980628984; its P/E ratio is 9.26; and it has a dividend yield of 7.15%. Guangzhou Baiyunshan Pharmaceutical Holdings Company is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
